View Item 

Show simple item record

Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens
dc.contributor.authorDaniels, G. L.en_US
dc.contributor.authorFletcher, A.en_US
dc.contributor.authorGarratty, G.en_US
dc.contributor.authorHenry, S.en_US
dc.contributor.authorJørgensen, J.en_US
dc.contributor.authorJudd, W. Johnen_US
dc.contributor.authorLevene, C.en_US
dc.contributor.authorLomas-Francis, Christineen_US
dc.contributor.authorMoulds, J. J.en_US
dc.contributor.authorMoulds, J. M.en_US
dc.contributor.authorMoulds, M.en_US
dc.contributor.authorOverbeeke, M.en_US
dc.contributor.authorReid, Marion E.en_US
dc.contributor.authorRouger, P.en_US
dc.contributor.authorScott, M.en_US
dc.contributor.authorSistonen, P.en_US
dc.contributor.authorSmart, E.en_US
dc.contributor.authorTani, Y.en_US
dc.contributor.authorWendel, S.en_US
dc.contributor.authorZelinski, T.en_US
dc.date.accessioned2010-06-01T20:20:36Z
dc.date.available2010-06-01T20:20:36Z
dc.date.issued2004-11en_US
dc.identifier.citationDaniels, G. L.; Fletcher, A.; Garratty, G.; Henry, S.; JØrgensen, J.; Judd, W. J.; Levene, C.; Lomas-Francis, C.; Moulds, J. J.; Moulds, J. M.; Moulds, M.; Overbeeke, M.; Reid, M. E.; Rouger, P.; Scott, M.; Sistonen, P.; Smart, E.; Tani, Y.; Wendel, S.; Zelinski, T. (2004). "Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens." Vox Sanguinis 87(4): 304-316. <http://hdl.handle.net/2027.42/73460>en_US
dc.identifier.issn0042-9007en_US
dc.identifier.issn1423-0410en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73460
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15585029&dopt=citationen_US
dc.format.extent146187 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Ltden_US
dc.rights© 2004 Blackwell Publishing Ltden_US
dc.subject.otherBlood Groupsen_US
dc.subject.otherTerminologyen_US
dc.subject.otherGeneticsen_US
dc.titleBlood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigensen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pathology, University Hospitals UH-2G332, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationotherBristol Institute for Transfusion Sciences, Bristol, UKen_US
dc.contributor.affiliationotherGrowing your Knowledge, Spit Junction, NSW, Australiaen_US
dc.contributor.affiliationotherAmerican Red Cross Blood Services, Los Angeles-Orange Counties Region, Los Angeles, CA, USAen_US
dc.contributor.affiliationotherBiotechnology Research Centre, Auckland University of Technology, Auckland, New Zealanden_US
dc.contributor.affiliationotherRegional Blood Transfusion Center, Department of Clinical Immunology, University Hospital, Århus N, Denmarken_US
dc.contributor.affiliationotherReference Laboratory for Immunohematology and Blood Groups, National Blood Services Centre, Tel Hashomer, Israelen_US
dc.contributor.affiliationotherNew York Blood Center, New York, NY, USAen_US
dc.contributor.affiliationotherOrtho-Clinical Diagnostics, Raritan, NJ, USAen_US
dc.contributor.affiliationotherDrexel University College of Medicine, Philadelphia, PA, USAen_US
dc.contributor.affiliationotherGamma Biologicals Inc (subsidiary of Immunocor Inc), Houston, TX, USAen_US
dc.contributor.affiliationotherCentral Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, the Netherlandsen_US
dc.contributor.affiliationotherCentre national de RÉfÉrence pour les Groupes sanguines (CNTS), Paris, Franceen_US
dc.contributor.affiliationotherInternational Blood Group Reference Laboratory, Bristol, UKen_US
dc.contributor.affiliationotherFinnish Red Cross Blood Transfusion Service, Helsinki, Finlanden_US
dc.contributor.affiliationotherSouth African National Blood Service, East Coast Region, Pinetown, South Africaen_US
dc.contributor.affiliationotherOsaka Red Cross Blood Center, Osaka, Japanen_US
dc.contributor.affiliationotherBlood Bank, Hospital Sirio-Libanes, SÃo Paulo, Brazilen_US
dc.contributor.affiliationotherRh Laboratory, University of Manitoba, Winnipeg, Manitoba, Canadaen_US
dc.identifier.pmid15585029en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73460/1/j.1423-0410.2004.00564.x.pdf
dc.identifier.doi10.1111/j.1423-0410.2004.00564.xen_US
dc.identifier.sourceVox Sanguinisen_US
dc.identifier.citedreferenceLewis M, Anstee DJ, Bird GWG, Brodheim E, Cartron J-P, Contreras M, Crookston MC, Dahr W, Daniels GL, Engelfriet CP, Giles CM, Issitt PD, JØrgensen J, Kornstad L, Lubenko A, Marsh WL, McCreary J, Moore BPL, Morel P, Moulds JJ, Nevanlinna H, Nordhagen R, Okubo Y, Rosenfield RE, Rouger Ph, Rubinstein P, Salmon Ch, Seidl S, Sistonen P, Tippett P, Walker RH, Woodfield G, Young S: Blood group terminology 1990. From the ISBT Working Party on Terminology for Red Cell Surface Antigens. Vox Sang 1990; 58: 152 – 169en_US
dc.identifier.citedreferenceDaniels GL, Anstee DJ, Cartron JP, Dahr W, Issitt PD, JØrgensen J, Kornstad L, Levene C, Lomas-Francis C, Lubenko A, Mallory D, Moulds JJ, Okubo Y, Overbeeke M, Reid ME, Rouger P, Seidl S, Sistonen P, Wendel S, Woodfield G, Zelinski T: Blood Group Terminology 1995: From the ISBT Working Party on Terminology for Red Cell Surface Antigens. Vox Sang 1995; 69: 265 – 279en_US
dc.identifier.citedreferenceDaniels GL, Anstee DJ, Cartron JP, Dahr W, Henry S, Issitt PD, JØrgensen J, Judd WJ, Kornstad L, Levene C, Lomas-Francis C, Lubenko A, Mallory D, Moulds JM, Moulds JJ, Okubo Y, Overbeeke M, Reid ME, Rouger P, Seidl S, Sistonen P, Wendel S, Zelinski T: Terminology for red cell surface antigens. Makuhari report. Vox Sang 1996; 71: 246 – 248en_US
dc.identifier.citedreferenceDaniels GL, Anstee DJ, Cartron JP, Dahr W, Garratty G, Henry S, JØrgensen J, Judd WJ, Kornstad L, Levene C, Lomas-Francis C, Lubenko A, Moulds JJ, Moulds JM, Moulds M, Overbeeke M, Reid ME, Rouger P, Scott M, Seidl S, Sistonen P, Tani Y, Wendel S, Zelinski T: Terminology for red cell surface antigens. ISBT Working Party Oslo report. Vox Sang 1999; 77: 52 – 57en_US
dc.identifier.citedreferenceDaniels GL, Anstee DJ, Cartron JP, Dahr W, Fletcher A, Garratty G, Henry S, JØrgensen J, Judd WJ, Kornstad L, Levene C, Lin M, Lomas-Francis C, Lubenko A, Moulds JJ, Moulds JM, Moulds M, Overbeeke M, Reid ME, Rouger P, Scott M, Sistonen P, Smart E, Tani Y, Wendel S, Zelinski T: Reports and guidelines. International Society of Blood Transfusion Working Party on terminology for red cell surface antigens. Vox Sang 2001; 80: 193 – 196en_US
dc.identifier.citedreferenceDaniels GL, Cartron JP, Fletcher A, Garratty G, Henry S, JØrgensen J, Judd WJ, Levene C, Lin M, Lomas-Francis C, Moulds JJ, Moulds JM, Moulds M, Overbeeke M, Reid ME, Rouger P, Scott M, Sistonen P, Smart E, Wendel S, Zelinski T: International Society of Blood Transfusion Commitee on terminology for red cell surface antigens. Vox Sang 2003; 84: 244 – 247en_US
dc.identifier.citedreferenceOlivÈs B, Mattei M-G, Huet M, Neau P, Martial S, Cartron JP, Bailly P: Kidd blood group and urea transport function of human erythrocytes are carried by the same protein. J Biol Chem 1995; 270: 15607 – 15610en_US
dc.identifier.citedreferenceSidoux-Walter F, Lucien N, OlivÈs B, Gobin R, Rousselet G, Kamsteeg EJ, Ripoche P, Deen PM, Cartron JP, Bailly P: At physiological expression levels the Kidd blood group/urea transporter protein is not a water channel. J Biol Chem 1999; 274: 30228 – 30235en_US
dc.identifier.citedreferenceWagner FF, Poole J, Flegel WA: The Scianna antigens including Rd are expressed by ERMAP. Blood 2002; 101: 752 – 757en_US
dc.identifier.citedreferenceEiberg H, Mohr J: Dombrock blood group ( DO ): assignment to chromosome 12p. Hum Genet 1996; 98: 518 – 521en_US
dc.identifier.citedreferenceGubin AN, Njoroge JM, Wojda U, Pack SD, Rios M, Reid ME, Miller JL: Identification of the Dombrock blood group glycoprotein as a polymorphic member of the ADP-ribosyltransferase gene family. Blood 2000; 96: 2621 – 2627en_US
dc.identifier.citedreferenceSpring FA, Homes CH, Simpson KL, Mawby WJ, Mattes MJ, Okubo Y, Parsons SF: The Ok a blood group antigen is a marker for the M6 leukocyte activation antigen, the human homolog of OX-47 antigen, basigin and neurothelin, an immunoglobulin superfamily molecule that is widely expressed in human cells and tissues. Eur J Immunol 1997; 27: 891 – 897en_US
dc.identifier.citedreferenceDaniels GL, Tippett P, Palmer DK, Miller YE, Geyer D, Jones C: MER2: a red cell polymorphism defined by monoclonal antibodies. Vox Sang 1987; 52: 107 – 110en_US
dc.identifier.citedreferenceDaniels GL, Levene C, Berrebi A, Schechter Y, Moulds M, Sela R, Poole J, Lacey P, Atkins CJ: Human alloantibodies detecting a red cell antigen apparently identical to MER2. Vox Sang 1988; 55: 161 – 164en_US
dc.identifier.citedreferenceKaramatic Crew V, Burton N, Kagan A, Green CA, Levene C, Flinter F, Brady LR, Daniels G, Anstee DJ: CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes, is essential for the correct assembly of human basement membranes in kidney and skin. Blood 2004; 104: 2217 – 2223.en_US
dc.identifier.citedreferenceMudad R, Rao N, Angelisova P, Horejsi V, Telen MJ: Evidence that CDw108 membrane protein bears the JMH blood group antigen. Transfusion 1995; 35: 566 – 570en_US
dc.identifier.citedreferenceYamada A, Kubo K, Takeshita T, Harashima N, Kawano K, Mine T, Sagawa K, Sugamura K, Itoh K: Molecular cloning of a glycosylphosphatidylinositol-anchored molecule CDw108. J Immunol 1999; 162: 4094 – 4100en_US
dc.identifier.citedreferenceYu L-C, Twu Y-C, Chang C-Y, Lin M: Molecular basis of the adult i phenotype and the gene responsible for the expression of the human blood group I antigen. Blood 2001; 98: 3840 – 3845en_US
dc.identifier.citedreferenceYu L-C, Twu Y-C, Chou M-L, Reid ME, Gray AR, Moulds JM, Chang C-Y, Lin M: The molecular genetics of the human I locus and molecular background explaining the partial association of the adult I phenotype with congenital cataracts. Blood 2003; 101: 2081 – 2088en_US
dc.identifier.citedreferenceOkajima T, Nakamura Y, Uchikawa M, Haslam DB, Numata Furukawa K, Urano T, Furukawa K: Expression cloning of human globoside synthase cDNAs. Identification of β3Gal-T3 as UDP- N -acetylgalactosamine: globotriosylceramide β1,3- N -acetylgalactosaminyltransferase. J Biol Chem 2000; 275: 40498 – 40503en_US
dc.identifier.citedreferenceHellberg Å, Poole J, Olsson ML: Molecular basis of the globoside-deficient P k blood group phenotype. Identification of four inactivating mutations in the UDP- N -acetylgalactosamine: globotriaosylceramide 3-β- N -acetylgalactosaminyltransferase gene. J Biol Chem 2002; 277: 29455 – 29459en_US
dc.identifier.citedreferenceDaniels GL, DeLong EN, Hare V, Johnson ST, LePennec PY, Mallory D, Marshall MJ, Oliver C, Spruell P: GIL: a red cell antigen of very high frequency. Immunohematology 1998; 14: 49 – 52en_US
dc.identifier.citedreferenceRoudier N, Ripoche P, Gane P, Le Pennec PY, Daniels G, Cartron JP, Bailly P: AQP3-deficiency in humans and molecular basis of a novel blood group system, GIL. J Biol Chem 2002; 277: 45854 – 45859en_US
dc.identifier.citedreferenceden Dunnen JT, Antonarakis E: Nomenclature for the description of human sequence variations. Hum Genet 2001; 109: 121 – 124en_US
dc.identifier.citedreferenceGarratty G, Dzik W, Issitt PD, Lublin DM, Reid ME, Zelinski T: Terminology for blood group antigens and genes-historical origins and guidelines in the new millennium. Transfusion 2000; 40: 477 – 489en_US
dc.identifier.citedreferencePoole J, Banks JA, Bruce LJ, Ring SM, Tanner MJA, Levene C: A novel glycophorin A polymorphism affecting Wr b expression. Transfusion 1995; 35: 40S (Abstract)en_US
dc.identifier.citedreferenceJarolim P, Moulds JM, Moulds JJ, Rubin HL, Dahr W: MARS and AVIS blood group antigens: polymorphism of glycophorin A affects band 3 glycophorin A interaction. Blood 1996; 88: 182a (Abstract)en_US
dc.identifier.citedreferenceSpruell P, Moulds JJ, Martin M, Gilcher RO, Howard PB, Blumenfeld OO: An anti-En a TS detected in the serum of an Mi I homozygote. Transfusion 1993; 33: 848 – 851en_US
dc.identifier.citedreferenceIwamura K, Furukawa K, Uchikawa M, Sojka BN, Kojima Y, Wiels J, Shiku H, Urano T, Furukawa K: The blood group P1 synthase gene is identical to the Gb3/CD77 synthase gene: a clue to the solution of the P1/P2/, p. puzzle. J Biol Chem 2003; 45: 44429 – 44438en_US
dc.identifier.citedreferenceHellberg Å: Sixteen polymorphic sites in the 5′/3′-UTR of the P k gene do not correlate with P1/P2 phenotypes. Vox Sang 2004; 87 ( suppl 3 ): 81 (Abstract)en_US
dc.identifier.citedreferenceTippett P, Lomas-Francis C, Wallace M: The Rh antigen D: partial D antigens and associated low incidence antigens. Vox Sang 1996; 70: 123 – 131en_US
dc.identifier.citedreferenceGreen C, Coghlan G, Bizot M, Kasulke D, Bombail-Girard M, Wallace M, Lomas-Francis C, Daniels G: JAHK: a low frequency antigen associated with the r G complex of the Rh blood group system. Transfus Med 2002; 12: 55 – 61en_US
dc.identifier.citedreferenceReid ME, Storry JR, Sausais L, Tossas E, Rios M, Hue-Roye K, Gloster ES, Miller ST, Wolf C, Lomas-Francis C: DAK, a new low-incidence antigen in the Rh blood group system. Transfusion 2003; 43: 1394 – 1397en_US
dc.identifier.citedreferenceCoghlan G, Zelinski T: DNA microsatellite and linkage analysis supports the inclusion of LOCR in the Rh blood group system. Transfusion 2003; 43: 440 – 444en_US
dc.identifier.citedreferenceWesthoff CM, Storry JR, Walker P, Lomas-Francis C, Reid ME: A new hybrid RHCE gene (CeNR) is responsible for expression of a novel antigen. Transfusion 2004; 44: 1047 – 1051en_US
dc.identifier.citedreferenceScott ML, Anstee DJ, Cartron J-P, Dahr W, Daniels G, Fletcher A, Garratty G, Henry S, Jorgensen J, Judd WJ, Levene C, Lin M, Lomas-Francis C, Moulds JJ, Moulds JM, Moulds M, Overbeeke M, Reid ME, Rouger P, Sistonen P, Smart E, Tani Y, Wendel S, Zelinski T: International Society of Blood Transfusion Working Party on Terminology for Red Cell Surface Antigens – terminology for epitopes and variant antigens of Rh D (004001; RH1). Vox Sang 2004; in pressen_US
dc.identifier.citedreferenceLomas C, McColl K, Tippett P: Further complexities of the Rh antigen D disclosed by testing category DII cells with monoclonal anti-D. Transfus Med 1993; 3: 67 – 69en_US
dc.identifier.citedreferenceKaramatic Crew V, Poole J, Banks J, Reed M, Daniels G: LU21: a new antigen in the Lutheran blood group system. Vox Sang 2004; 87: 109 – 113.en_US
dc.identifier.citedreferenceLee S, Reid ME, Redman CM: Point mutations in KEL exon 8 determine a high-incidence (RAZ) and a low-incidence (KEL25, VLAN) antigen of the Kell blood group system. Vox Sang 2001; 81: 259 – 263en_US
dc.identifier.citedreferenceGrey D, Poole J, Martin P, Condon J, Allwright J, O'Day S, Daniels G: Haemolytic disease of the newborn caused by a new Kell antigen. Transfus Med 2003; 13 ( suppl 1 ): 30 (Abstract)en_US
dc.identifier.citedreferenceLee S: Molecular basis of Kell blood group phenotypes. Vox Sang 1997; 73: 1 – 11 and Vox Sang 1998; 74: 58en_US
dc.identifier.citedreferenceHenry S, Oriol R, Samuelsson B: Lewis histo-blood group system and associated secretory phenotypes. Vox Sang 1995; 69: 166 – 182en_US
dc.identifier.citedreferenceBruce LJ, Zelinski T, Ridgwell K, Tanner MJA: The low-incidence blood group antigen, Wd a, is associated with the substitution Val 557 → Met in human erythrocyte band 3 ( AE1 ). Vox Sang 1996; 71: 118 – 120en_US
dc.identifier.citedreferenceJarolim P, Murray JL, Rubin HL, Smart E, Moulds JM: Blood group antigens Rb a, Tr a, and Wd a are located in the third ectoplasmic loop of erythroid band 3. Transfusion 1997; 37: 607 – 615en_US
dc.identifier.citedreferenceJarolim P, Murray JL, Rubin HL, Coghlan G, Zelinski T: A Thr 552 → Ile substitution in erythroid band 3 gives rise to the Warrior blood group antigen. Transfusion 1997; 37: 398 – 405en_US
dc.identifier.citedreferenceZelinksi T, Punter F, McManus K, Coghlan G: The ELO blood group polymorphism is located in the putative first extracellular loop of human erythrocyte band 3. Vox Sang 1998; 75: 63 – 65en_US
dc.identifier.citedreferenceJarolim P, Rubin HL, Zakova D, Storry J, Reid ME: Characterization of seven low incidence blood group antigens carried by erythrocyte band 3 protein. Blood 1998; 92: 4836 – 4843en_US
dc.identifier.citedreferenceZelinski T, McManus K, Punter F, Moulds M, Coghlan G: A Gly 565  → Ala substitution in human erythrocyte band 3 accounts for the Wu blood group polymorphism. Transfusion 1998; 38: 745 – 748en_US
dc.identifier.citedreferenceZelinski T, Rusnak A, McManus K, Coghlan G: Distinctive Swann blood group genotypes: molecular investigations. Vox Sang 2000; 79: 215 – 218en_US
dc.identifier.citedreferencePoole J, Bruce LJ, Hallewell H, Kusnierz-Alejska G, Zupanska B, Daniels GL, Tanner MJA: Erythrocyte band 3 mutation Pro561 → Ser givers rise BOW antigen Pro566 → Ala to a novel antigen KREP. Transfus Med 1998; 8 ( suppl 1 ): 17 (Abstract)en_US
dc.identifier.citedreferenceMcManus K, Pongoski J, Coghlan G, Zelinski T: Amino acid substitutions in human erythroid protein, band 3 account for the low-incidence antigens NFLD and BOW. Transfusion 2000; 40: 325 – 329en_US
dc.identifier.citedreferencePoole J, Hallewell H, Bruce L, Tanner MJA, Zupanska B, Kusnierz-Alejska G: Identification of two new Jn(a+) individuals and assignment of Jn a to erythrocyte band 3. Transfusion 1997; 37: 90S (Abstract)en_US
dc.identifier.citedreferenceMcManus K, Lupe K, Coghlan G, Zelinski T: An amino acid substitution in the putative second extracellular loop of RBC band 3 accounts for the Froese blood group polymorphism. Transfusion 2000; 40: 1246 – 1249en_US
dc.identifier.citedreferenceTippett P, Ellis N: The Xg blood group system: a review. Transfus Med Rev 1998; 12: 233 – 257en_US
dc.identifier.citedreferenceUchikawa M, Tsuneyama H, Tadokoro K, Juji T, Yamada M, Maeda Y: An alloantibody to 12E7 antigen detected in 2 healthy donors. Transfusion 1995; 35: 23S (Abstract)en_US
dc.identifier.citedreferenceHue-Roye K, Chaudhuri A, Velliquette RW, Thomas R, Balk M, Reid ME: A novel high prevalence antigen in the Scianna blood group system. Vox Sang 2004; 87 ( suppl 3 ): 40 (Abstract)en_US
dc.identifier.citedreferenceYabe R, Uchikawa M, Tuneyama H, Ogasawara K, Toyoda T, Suzuki Y, Shimizu H, Uchida S, Nakajima K: IS: a new Gerbich blood group antigen located on the GPC and GPD. Vox Sang 2004; 87 ( suppl 3 ): 79 (Abstract)en_US
dc.identifier.citedreferenceStorry JR, Sausais L, Hue-Roye K, Mudiwa F, Ferrer Z, Blajchman MA, Lublin DM, Ma B-W, Miquel JF, Nervi F, Pereira J, Reid ME: GUTI: a new antigen in the Cromer blood group system. Transfusion 2003; 43: 340 – 344en_US
dc.identifier.citedreferenceBanks J, Poole J, Ahrens N, Seltsam A, Salama A, Hue-Roye K, Storry JR, Palacajornsuk P, Ma B-W, Lublin DM, Reid ME: SERF: a new antigen in the Cromer blood group system. Transfus Med 2004; 14: 313 – 318en_US
dc.identifier.citedreferenceHue-Roye K, Powell V, Barnes J, Chung A, Fung Kee Fung K, Kinney J, Lublin D, Belaygorod. L, Reid M: ZENA: A new high prevalence Cromer blood group antigen. Transfusion 2004; 44: 26A (Abstract)en_US
dc.identifier.citedreferenceMoulds JM, Zimmerman PA, Doumbo OK, Kassambara L, Sagara I, Diallo DA, Atkinson JP, Krych-Goldberg M, Hauhart RE, Hourcade DE, McNamara DT, Birmingham DJ, Rowe JA, Moulds JJ, Miller LH: Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood 2001; 97: 2879 – 2885en_US
dc.identifier.citedreferenceMoulds JM, Zimmerman PA, Doumbo OK, Diallo DA, Atkinson JP, Krych-Goldberg M, Hourcade DE, Moulds JJ: Expansion of the Knops blood group system and subdivision of Sl a. Transfusion 2002; 42: 251 – 256en_US
dc.identifier.citedreferenceSchechter Y, Chezar J, Levene C, Poole J, Moulds M, Daniels G: ABTI (901015), a new red cell antigen of high frequency. Transfusion 1996; 36: 25S (Abstract)en_US
dc.identifier.citedreferenceBanks J, Poole J, Das Gupta C, Lonicer C, Salama A: Two new cases of nti–ABTI showing an association between ABTI and Vel. Vox Sang 2004; 87 ( suppl 3 ): 38 (Abstract)en_US
dc.identifier.citedreferenceArriaga F, Mueller A, Rodberg K, Ciesielski D, Poole J, Banks J, de La Rubia J, Carpio N, Marty ML, Garratty G: A new antigen of the Er collection. Vox Sang 2003; 84: 137 – 139en_US
dc.identifier.citedreferenceMontgomery WM, Jr, Nance SJ, Donnelly SF, Brady TW, Anderson G, Mintz PD, Moulds MK, Daniels GL, Spring FA, Molina N, de Asis EA, Olivares E: MAM: a ‘new’ high-incidence antigen found on multiple cell lines. Transfusion 2000; 40: 1132 – 1139en_US
dc.identifier.citedreferenceMontiel M-D, Krzewinski-Recchi M-A, Delannoy P, Harduin-Lepers A: Molecular cloning, gene organization and expression of human UDP-GalNAc: Neu5AcΑ2–3Galβ-R β1,4- N -acetylgalactosaminyltransferase responsible for the biosynthesis of the blood group Sd a /Cad antigen: evidence for an unusual extended cytoplasmic domain. Biochem J 2003; 373: 369 – 379en_US
dc.identifier.citedreferencePresti LL, Cabuy E, Chiricolo M, Dall’olio F: Moleculer cloning of the human β1, 4 N -acetylgalactosaminyltransferase responsible for the biosynthesis of the Sol a histo-blood group antigen: the sequence predicts a very long aytoplasmic domain. J Biochem 2003; 134: 675 – 682en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1423-0410.2004.00564.x.pdf
Size:
142.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.